🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to assess safety of FIXFc at doses ra...
Status
Completed
Location
RUSH University Medical Center
Start Date
2008-04
Trial ID
NCT00716716
Treatments Being Tested
A Phase 1/2, open-label, dose-finding safety study of single ascending dose...
Status
Terminated
Location
Arkansas Children's Hospital
Start Date
2015-12-16
Trial ID
NCT02618915
Treatments Being Tested
The primary objective of the study is to evaluate the effectiveness of prop...
Status
Terminated
Location
Research Site
Start Date
2015-07
Trial ID
NCT02392156
Treatments Being Tested
The primary objective of the study was to evaluate the safety of recombinan...
Status
Completed
Location
Research Site
Start Date
2014-11-13
Trial ID
NCT02234310
Treatments Being Tested
This study aims to compare the incidence of thromboembolic complications am...
Status
Recruiting
Location
UF Health Jacksonville (Shands Hospital)
Start Date
2026-04-30
Trial ID
NCT07290634
Treatments Being Tested
This trial will enroll patients with severe hemophilia A. Experiments will ...
Status
Completed
Location
Tulane University Lakeside Hospital and Clinics
Start Date
2022-08-01
Trial ID
NCT05281718
Treatments Being Tested
Primary: To characterize the safety of RIXUBIS when used under normal clini...
Status
Completed
Location
Daegu Catholic University Medical Center
Start Date
2017-01-06
Trial ID
NCT02922231
Treatments Being Tested
This is a non-interventional, multicenter, observational, international stu...
Status
Recruiting
Location
Arthur M. Blank Hospital
Start Date
2020-03-17
Trial ID
NCT04023019
Primary Objective: To evaluate the safety (acute effects associated with i...
Status
Completed
Location
City of Hope
Start Date
2009-01
Trial ID
NCT00768287
Treatments Being Tested
The purpose of the study is to assess the safety, efficacy and pharmacokine...
Status
Completed
Location
University of Colorado Denver Hemophilia & Thrombosis Center
Start Date
2015-12-07
Trial ID
NCT02448680
Treatments Being Tested